A crosslinkable coating composition comprising: ingredient A that has at least two protons that can be activated to form a Michael carbanion donor; ingredient B that functions as a Michael acceptor having at least two ethylenically unsaturated functionalities each activated by an electron-withdrawing group; and a dormant carbamate initiator of Formula (1) ##STR00001##
wherein R.sub.1 and R.sub.2 can be independently selected from hydrogen, a linear or branched substituted or unsubstituted alkyl group having 1 to 22 carbon atoms; 1 to 8 carbon atoms; and A.sup.n+ is a cationic species or polymer and n is an integer equal or greater than 1 with the proviso that A.sup.n+ is not an acidic hydrogen; and optionally further comprising ammonium carbamate (H.sub.2NR.sub.1R.sub.2.sup.+OCONR.sub.1R.sub.2). The crosslinkable coating composition can be used for a variety of coating applications including nail coating compositions.

A method for capturing CO.sub.2 comprising dissolving at least one pure amino acid (AA) in water without the use of a catalyst for establishing protonation of an amino group of the amino acid, adding at least one base solution to the amino acid and water solution to deprotonate the protonated amino group of the amino acid and forming an amino acid-XOHH.sub.2O wherein X is sodium or potassium, and subjecting CO.sub.2 to the amino acid-XOHH.sub.2O to form new nanomaterials is provided. A regenerable nanofiber is disclosed comprising a NaHCO.sub.3 nanofiber, a KHCO.sub.3 nanofiber, or an amino acid nanofiber made from subjecting a CO.sub.2 gas to an amino acid aqueous solvent. Preferably, the amino acid aqueous solvent is one or more of a Gly-NaOHH.sub.2O, an Ala-NaOHH.sub.2O, a Phe-NaOHH.sub.2O, a Gly-KOHH.sub.2O, an Ala-KOHH.sub.2O, and a Phe-KOHH.sub.2O.

A method for capturing CO.sub.2 comprising dissolving at least one pure amino acid (AA) in water without the use of a catalyst for establishing protonation of an amino group of the amino acid, adding at least one base solution to the amino acid and water solution to deprotonate the protonated amino group of the amino acid and forming an amino acid-XOHH.sub.2O wherein X is sodium or potassium, and subjecting CO.sub.2 to the amino acid-XOHH.sub.2O to form new nanomaterials is provided. A regenerable nanofiber is disclosed comprising a NaHCO.sub.3 nanofiber, a KHCO.sub.3 nanofiber, or an amino acid nanofiber made from subjecting a CO.sub.2 gas to an amino acid aqueous solvent. Preferably, the amino acid aqueous solvent is one or more of a Gly-NaOHH.sub.2O, an Ala-NaOHH.sub.2O, a Phe-NaOHH.sub.2O, a Gly-KOHH.sub.2O, an Ala-KOHH.sub.2O, and a Phe-KOHH.sub.2O.

A method for capturing CO.sub.2 comprising dissolving at least one pure amino acid (AA) in water without the use of a catalyst for establishing protonation of an amino group of the amino acid, adding at least one base solution to the amino acid and water solution to deprotonate the protonated amino group of the amino acid and forming an amino acid-XOHH.sub.2O wherein X is sodium or potassium, and subjecting CO.sub.2 to the amino acid-XOHH.sub.2O to form new nanomaterials is provided. A regenerable nanofiber is disclosed comprising a NaHCO.sub.3 nanofiber, a KHCO.sub.3 nanofiber, or an amino acid nanofiber made from subjecting a CO.sub.2 gas to an amino acid aqueous solvent. Preferably, the amino acid aqueous solvent is one or more of a Gly-NaOHH.sub.2O, an Ala-NaOHH.sub.2O, a Phe-NaOHH.sub.2O, a Gly-KOHH.sub.2O, an Ala-KOHH.sub.2O, and a Phe-KOHH.sub.2O.

The present invention relates to compounds of formula (I) and to pharmaceutical compositions containing them:

##STR00001##

wherein meanings of the substituents are indicated in the description.

Such compounds for use in the treatment of cancer and other diseases related to altered angiogenesis, such as arthritic pathology, diabetic retinopathy, psoriasis and chronic inflammatory disease, are also within the scope of the present invention.

The present invention relates to an amino acid-based compound for detecting carbon dioxide, and to a carbon dioxide chemical sensor and a carbon dioxide detection method using the compound, wherein the compound having selectivity with respect to carbon dioxide exhibits a high selectivity to carbon dioxide and thus may detect carbon dioxide of a very low concentration, exhibits excellent light-absorbing or fluorescent characteristics, and, in particular, may achieve an effect of detecting carbon dioxide in real time.

The present invention relates to an amino acid-based compound for detecting carbon dioxide, and to a carbon dioxide chemical sensor and a carbon dioxide detection method using the compound, wherein the compound having selectivity with respect to carbon dioxide exhibits a high selectivity to carbon dioxide and thus may detect carbon dioxide of a very low concentration, exhibits excellent light-absorbing or fluorescent characteristics, and, in particular, may achieve an effect of detecting carbon dioxide in real time.

Described herein are methods for quantitatively determining the amount of the amphetamine-related compound identified herein as amphetamine carbamate (amphetammonium-amphetacarbamate) present in a drug-containing polymer matrix comprising amphetamine, and for assessing a drug-containing polymer matrix comprising amphetamine. The methods may comprise converting any amphetacarbamate present into reaction products comprising carbonate, quantifying the amount of carbonate, and quantifying the amphetacarbamate originally present from the quantified amount of carbonate.

The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.

The present invention relates to a method of treating cataplexy in a subject in need thereof, comprising administering to the subject a therapeutically effective amount of certain carbamate compounds.